Skip to content

Evaluating a special balloon to treat calcified coronary stenosis

a Dutch multicenter registry evaluating Hertz Contact intravascular lithotripsy balloon for calcified coronary lesions - D Lithix

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58571
Enrollment
5
Registered
2026-04-09
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome, chronic coronary syndrome, angina pectoris, calcified coronary lesions coronary artery disease, angina pectoris

Interventions

Use of Lithix balloon (Hertz contact intravascular lithotripsy)

Sponsors

St. Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subject is aged 18 to 85 years Presentation with stable angina or stable NSTE-ACS with de novo native significant lesion > 70 % stenosis or 50-70 % stenosis with evidence of hemodynamic significanceSignificant calcification is defined either as:> 270° arc of calcium > 5 mm length on high definition intravasculair ultrasound HD-IVUS360° arc of calcium on HD-IVUS

Exclusion criteria

Exclusion criteria: STEMI within 30 daysLVEF < 25 %Cardiogenic shock or anticipated mechanical/pharmacological supportExcessive tortuosity or anatomic considerations precluding intravascular imagingTarget vessel dissection.

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is device and procedural success.- Device success is defined as HC-IVL balloon delivery and balloon inflation without complications. - Procedural success defined as technical success without in-hospital major adverse cardiovascular events ((MACE): composite of cardiovascular death, myocardial infarction and target vessel revascularization).  - Technical success is defined as MSA = 5 in non-left main and MSA = 8 in left main coronary artery with final TIMI 3 flow and residual stenosis <30%.

Secondary

MeasureTime frame
Post-procedural stent area at the point of maximum calcification as measured by intravascular imaging with HD-IVUS.- Safety endpoints include procedural complications and MACE up to two-year follow-upHD-IVUS characteristics: fractures, MSA, stent area, acute area gain and stent expansion (defined as stent area/ average reference lumen area x 100) Periprocedural complications: flow limiting dissection, perforation, no-reflow, periprocedural myocardial infarction, acute stent thrombosisAngiographic outcomes: acute gain and residual diameter stenosis.Clinical outcomes: MACE, and follow up will be performed at 30 days and at regular intervals up to 2 years after the index procedure. 

Countries

Netherlands

Contacts

Public ContactM.A. Schotborgh

St. Antonius Ziekenhuis

m.schotborgh@antoniusziekenhuis.nl0883201751

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 16, 2026